Overcoming Barriers to Diagnosis of CKD in Type 2 Diabetes

We are delighted to invite you to our Live event, ‘Overcoming Barriers to Diagnosis of Chronic Kidney Disease in Type 2 Diabetes’.

Register now to hear our panel of experts explore why regular urine albumin-to-creatinine ratio (UACR) testing is a simple yet essential tool for early detection of chronic kidney disease (CKD) in people living with type 2 diabetes.

Sign up today to join the conversation on Tuesday, December 2, 2025, 1:30 pm – 2:15 pm CET, with the following panelists:

Facilitator:
Professor Richard Hobbs, Mercian Professor of Primary Care, University of Oxford

Primary Care Physicians:
Dr. Ana María Cebrián Cuenca – Family Physician (GP), Murcian Health Service; Vice-Secretary, Spanish Diabetes Society (SED)
Dr Petra Sandow, Internal Medicine and General Medicine, Berlin, Germany

Patient advocates:
Elisabeth Dupont – Regional Manager, IDF Europe
Aditi Khandelwal – Co-Founder, Heart Health India Foundation

Key topics for discussion include:
How regular UACR testing can enable early detection of CKD and help prevent cardiovascular (CV) complications
The key barriers to greater uptake of UACR testing
Opportunities and actionable steps to overcome these barriers and improve access to testing

The event will conclude with a Q&A session, giving attendees the chance to ask questions directly to our experts (only on LinkedIn).